Alain Makinson

Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial

Florence Ader, Maude Bouscambert‐Duchamp, Maya Hites et al. · The Lancet Infectious Diseases · 2021 · 338 citations · Full text

An open-label randomized controlled trial of the effect of lopinavir/ritonavir, lopinavir/ritonavir plus IFN-β-1a and hydroxychloroquine in hospitalized patients with COVID-19

Florence Ader, Nathan Peiffer‐Smadja, Julien Poissy et al. · Clinical Microbiology and Infection · 2021 · 102 citations · Full text

Clinical Infectious Disease, Open-label Randomized, Antiviral Drug Development +6

Simple Scoring System to Predict In‐Hospital Mortality After Surgery for Infective Endocarditis

Giuseppe Gatti, Andréa Perrotti, Jean‐François Obadia et al. · Journal of the American Heart Association · 2017 · 75 citations · Full text

HIV Neuroinfection and Alzheimer’s Disease: Similarities and Potential Links?

Geoffrey Canet, Chloé Dias, Audrey Gabelle et al. · Frontiers in Cellular Neuroscience · 2018 · 71 citations · Full text

Immunology, Tau Pathways, Social Sciences +22

Thalidomide for steroid-dependent immune reconstitution inflammatory syndromes during AIDS

Anne‐Sophie Brunel, Jacques Reynes, Édouard Tuaillon et al. · AIDS · 2012 · 69 citations

Inflammation, Primary Immunodeficiency, Thalidomide Treatment +12